An interdisciplinary team at the Medical University of South Carolina has shown that Neuropilin 2, a protein highly expressed in lung cancer cells, is a critical player in conferring resistance to targeted therapy in lung cancer. Their findings are reported in an article published in The Journal of Thoracic and Cardiovascular Surgery.
- For people with diabetes, medicaid expansion helps, but can’t do it all: BU study
- Research shows bariatric surgery may reduce severity of COVID-19 in patients with obesity
- COVID’s collateral damage: Germicidal lamps may damage corneas
- Microbes help unlock phosphorus for plant growth
- Simple new testing method aims to improve time-release drugs